Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$4.84 – $12.00
87% from low
No one on the platform currently holds MSCLF.
No tracked institution reports a position in MSCLF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-01-30 | 1-for-12reverse |
No one on the platform has traded MSCLF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $0 | — | $-0.15 | $-0.15–$-0.15 | — | 1 |
| 2027 | $0 | — | $-0.16 | $-0.16–$-0.16 | — | 1 |
| 2028 | $0 | — | $-0.14 | $-0.14–$-0.14 | — | 1 |
| 2029 | $14M | — | $-0.09 | $-0.09–$-0.09 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-03-27 | $-0.03 | $-6.00 | -19431.3% |
| 2025-11-14 | $-0.03 | $-0.03 | -10.3% |
| 2025-08-13 | $-0.02 | $-0.02 | +10.6% |
| 2025-05-13 | $-0.03 | $-0.04 | -27.2% |
| 2025-03-26 | $-0.05 | $-0.01 | +80.0% |
| 2024-11-13 | $-0.07 | $-0.05 | +28.6% |
| 2024-08-12 | $-0.07 | $-0.05 | +28.6% |
| 2024-05-14 | $-0.04 |
| $-0.04 |
| -8.4% |
| $112M |
| — |
| PBIGFParadigm Biopharmaceuticals Limited | $0.12 | +0.00% | $74M | — |
| POLBFPoolbeg Pharma PLC | $0.10 | +0.00% | $73M | — |
Source: Financial Modeling Prep · peers by sector/industry